Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2024
Smoking-Associated Carcinogen-Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation
Ritesh K Aggarwal, Simone Sidoli, Jingli Wang, et al.
The Journal of Clinical Investigation
|
February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma
Niraj Shenoy, Tushar D Bhagat, John Cheville, et al.
The Journal of Clinical Investigation
|
May 27, 2025
Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes
Srinivas Aluri, Te Ling, Ellen Fraint, et al.
Cell Metabolism
|
May 8, 2012
SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function
Nathan L Price, Ana P Gomes, Alvin J Y Ling, et al.
The Journal of Clinical Investigation
|
February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency
Sarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Elife
|
October 31, 2019
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
Tushar D Bhagat, Dagny Von Ahrens, Meelad Dawlaty, et al.
Nature Communications
|
May 13, 2026
Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis
Srinivas Aluri, Kimo Bachiashvili, Anjali Budhathoki, et al.
Research Square
|
March 3, 2023
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses
Marina Konopleva, Courtney DiNardo, Tushar Bhagat, et al.
Nature Cancer
|
September 19, 2024
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses
Courtney D DiNardo, Divij Verma, Natalia Baran, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2024
Smoking-Associated Carcinogen-Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation
Ritesh K Aggarwal, Simone Sidoli, Jingli Wang, et al.
The Journal of Clinical Investigation
|
February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma
Niraj Shenoy, Tushar D Bhagat, John Cheville, et al.
The Journal of Clinical Investigation
|
May 27, 2025
Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes
Srinivas Aluri, Te Ling, Ellen Fraint, et al.
Cell Metabolism
|
May 8, 2012
SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function
Nathan L Price, Ana P Gomes, Alvin J Y Ling, et al.
The Journal of Clinical Investigation
|
February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency
Sarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Elife
|
October 31, 2019
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
Tushar D Bhagat, Dagny Von Ahrens, Meelad Dawlaty, et al.
Nature Communications
|
May 13, 2026
Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis
Srinivas Aluri, Kimo Bachiashvili, Anjali Budhathoki, et al.
Research Square
|
March 3, 2023
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses
Marina Konopleva, Courtney DiNardo, Tushar Bhagat, et al.
Nature Cancer
|
September 19, 2024
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses
Courtney D DiNardo, Divij Verma, Natalia Baran, et al.
Page
of 4